Cargando…
Women and Alport syndrome
X-linked Alport syndrome (XLAS) is caused by mutations in type IV collagen causing sensorineural hearing loss, eye abnormalities, and progressive kidney dysfunction that results in near universal end-stage renal disease (ESRD) and the need for kidney transplantation in affected males. Until recent d...
Autor principal: | Rheault, Michelle N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223569/ https://www.ncbi.nlm.nih.gov/pubmed/21380623 http://dx.doi.org/10.1007/s00467-011-1836-7 |
Ejemplares similares
-
Targeting Fibrosis Pathways in Alport Syndrome—Is it Too Late?
por: Rheault, Michelle N.
Publicado: (2023) -
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative
por: Kashtan, Clifford E., et al.
Publicado: (2012) -
The importance of clinician, patient and researcher collaborations in Alport syndrome
por: Rheault, Michelle N., et al.
Publicado: (2019) -
Clinical trial recommendations for potential Alport syndrome therapies
por: Weinstock, B. André, et al.
Publicado: (2020) -
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome
por: Gross, Oliver, et al.
Publicado: (2017)